RxDoctor Payments Data

Jennifer Aronica, MD

Dermatology · Washington, DCNPI 1699160697

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 28.2% of the total. Reporting peaked in 2020 at $712 and has fallen 75.7% since, to $173 in 2025. That places this record below the midpoint for dermatology clinicians in DC, where the typical reported total is $3,159.

$2,960in general payments, 2019–2025

Across 121 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$835
  • Sanofi$367
  • Johnson & Johnson$224
  • Lilly USA, LLC$172
  • Amgen$168
  • Sun Pharmaceutical Industries Inc.$162
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,78094%
  • Education$1806%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,960 in reported general payments places this provider in the 45th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$287,378
Medicare patients
783
Services billed
5,133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate81$3,673
Fluorouracil45$2,937
Triamcinolone Acetonide115$1,434
Fluocinonide42$1,305
Clindamycin Phosphate43$1,284
Ketoconazole60$924
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc28$680
ValacyclovirValacyclovir Hcl14$505
Doxycycline Hyclate35$500
Hydrocortisone77$487
Metronidazole12$422
Mupirocin34$242
Doxycycline Monohydrate18$200

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →